EDGAR Filing Documents for 0001654954-17-009910

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001654954-17-009910

Filing Date

2017-11-01

Accepted

2017-11-01 17:10:48

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	azrxs3_nov12017.htm	S-3	316449
2	OPINION OF DISCLOSURE LAW GROUP, A PROFESSIONAL CORPORATION	ex5-1.htm	EX-5.1	20396
3	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - MAZARS USA LLP	ex23-2.htm	EX-23.2	4259
4	IMAGE	azurrx_logo000.jpg	GRAPHIC	5760
5	IMAGE	dlgfooter.jpg	GRAPHIC	3277
6	IMAGE	dlgheader.jpg	GRAPHIC	4549
	Complete submission text file	0001654954-17-009910.txt		361286

Mailing Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226

Business Address 760 PARKSIDE AVENUE SUITE 304 BROOKLYN NY 11226 646-699-7855

AzurRx BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: S-3 | Act: 33 | File No.: 333-221275 | Film No.: 171169836
SIC: 2834 Pharmaceutical Preparations